Background: Neuroactive steroids such as (3a,5a)3-hydroxypregnan-20-one (3a,5a-THP, allopregnanolone) are potent neuromodulators that enhance GABAergic neurotransmission and produce inhibitory neurobehavioral and anti-inflammatory effects. Chronic ethanol (EtOH) consumption reduces 3a,5a-THP levels in human plasma, but has brain region-and species-specific effects on central nervous system levels of 3a,5a-THP. We explored the relationship between 3a,5a-THP levels in the hippocampus and voluntary EtOH consumption in the cynomolgus monkey following daily self-administration of EtOH for 12 months and further examined the relationship with hypothalamic-pituitary-adrenal (HPA) axis function prior to EtOH exposure. We simultaneously explored hippocampus levels of monocyte chemoattractant protein 1 (MCP-1), a pro-inflammatory cytokine that plays an important role in the neuroimmune response to EtOH, following chronic self-administration.
THANOL (ETOH) CONSUMPTION leads to many and varied responses throughout the brain. A primary effect of EtOH administration on neural tissue is modulation of various neurotransmitter systems in the brain, namely that of c-aminobutyric acid (GABA). GABA type A receptors belong to a family of receptors that serve as ligand-gated chloride ion channels. The heteropentameric GABA A receptor acts to mediate much of the synaptic inhibition within the central nervous system (CNS). One class of molecules that has activity at these receptors are neuroactive steroids such as 3a-reduced metabolites of progesterone, the most potent of which is (3a,5a)-3-hydroxypregnan-20-one (3a,5a-THP or allopregnanolone). 3a,5a-THP acts as a positive allosteric modulator of GABA A receptors by potentiating sites within a subunits to enhance GABAergic activity, which produces pharmacological effects similar to those of EtOH administration. In studies of human and animal models, systemic administration of GABAergic neuroactive steroids leads to a number of varied pharmacological responses. Consistent with their actions at the GABA A receptor, those responses include analgesic, anesthetic, antidepressant, anxiolytic, anticonvulsant, and sedative effects (Belelli et al., 1989; Bitran et al., 1991; Carl et al., 1990; Kavaliers, 1988; Khisti et al., 2000) . Systemic EtOH has been shown to increase both brain levels and serum levels of neuroactive steroids (Serra et al., 2003; Vandoren et al., 2000) , and many of the pharmacological responses associated with EtOH are inhibited by enzymatic inhibition of steroidogenesis or adrenalectomy.
Chronic EtOH consumption leads to species-specific effects on neuroactive steroids. Human alcoholics have reduced 3a,5a-THP levels (Romeo et al., 1996) in their plasma, while Sprague Dawley rats do not (Janis et al., 1998) . Male rats that have become dependent on EtOH, however, exhibit tolerance to the induction of circulating 3a,5a-THP levels by EtOH. These rats also had reduced 3a,5a-THP in both cerebral cortex and in hippocampus (Cagetti et al., 2004) . Multiple brain regions have been shown to have reduced 3a,5a-THP levels in C57BL/6J mice dependent on alcohol, including the prefrontal cortex, ventral tegmental area (VTA), and lateral amygdala, while the hippocampus CA3 exhibits an increase in levels of this neuroactive steroid (Maldonado-Devincci et al., 2014) . While acute EtOH administration does not alter 3a,5a-THP levels in plasma of cynomolgus monkeys (Porcu et al., 2010) , chronic consumption leads to reductions in lateral amygdala, basolateral amygdala, and plasma in these monkeys (Beattie et al., 2017) . In a brain region-specific manner, neuroactive steroid levels in response to EtOH may be contributing to EtOH tolerance and increased consumption.
EtOH consumption results in increased pro-inflammatory signaling in the brain that is linked with alcohol use disorders and changes in drinking behavior (Agrawal et al., 2011; Blednov et al., 2005 Blednov et al., , 2012 . In humans, chronic, high-dose EtOH consumption can lead to direct suppression of multiple immune responses. It has also been reported that alcoholism can lead to increased incidences of infectious diseases (Romeo et al., 2007) . Innate immune system activation by EtOH is thought to occur via activation of the Toll-like receptor (TLR) family of receptors. The signaling pathway initiated by TLR4 regulates many pro-inflammatory cytokines in the CNS. TLR4 knockout mice show decreased expression of multiple pro-inflammatory cytokines (tumor necrosis factor [TNF]-a, interleukin [IL]-1b, IL-6) found in their wild-type counterparts (Alfonso-Loeches et al., 2010) . One cytokine, monocyte chemoattractant protein-1 (MCP-1, also known as CCL2) has been implicated in mediating both inflammation and alcohol drinking behavior in mice (Blednov et al., 2005) , and has been found to be increased in the amygdala, VTA, substantia nigra, and hippocampus of postmortem human alcoholic brains (He and Crews, 2008) . Alcohol-preferring P rats have innately elevated levels of TLR4 and MCP-1, and inhibiting gene expression of either factor results in reduced binge alcohol consumption (June et al., 2015) . It is currently unknown how dysfunction of neuroimmune signaling pathways may contribute to alcohol dependence. Similarly, it is unknown what relationship exists between neuroactive steroids such as 3a,5a-THP and neuroimmune factors like MCP-1.
In this study, we investigated the effects of long-term EtOH exposure on hippocampus levels of 3a,5a-THP and MCP-1. Hippocampus was chosen as a neuroanatomical site of action in part because the neuroactive steroid levels in response to EtOH in previous studies reveal alterations inconsistent with those found in other brain regions. Due to similarities in brain regions between humans and monkeys, these types of studies on nonhuman primates are essential toward understanding the complex biomedical disease processes affecting populations throughout the world. Cynomolgus macaques voluntarily self-administer EtOH at levels great enough to achieve intoxication with daily intake ranges similar to those seen in human social drinkers through those with alcohol use disorder (Grant et al., 2008) , indicating that they are an important translational model for studying neural adaptive responses related to excessive drinking. Approximately half of the monkeys (4 of the 9 alcohol-consuming animals) showed a "heavy drinking" phenotype of at least 3.0 g/kg/d (or >12-drink equivalent) over the 12 months of free access. The animals consumed EtOH and maintained blood EtOH concentrations similar to human alcoholics (Majchrowicz and Mendelson, 1970) , allowing us to assess a distribution that better reflects a population of humans, where only some will become "heavy drinkers" given free access. We have previously reported on reductions in both circulating and amygdalar levels of 3a,5a-THP after chronic EtOH consumption (Beattie et al., 2017) , and here, we see changes in hippocampus levels indicating a region-specific relationship between neuroactive steroids and EtOH consumption.
MATERIALS AND METHODS

Animals
Monkeys (Macaca fascicularis, 50 to 62 months of age, weight 3.84 to 5.74 kg, n = 9) used in these studies are the same monkeys previously used in numerous studies to assess neuroendocrine mechanisms associated with EtOH self-administration (Beattie et al., 2017; Jimenez et al., 2017; Porcu et al., 2006) . The monkeys were housed individually in cages that were adjacent to 3 other conspecifics in quarters maintained within a narrow range of temperature (68 to 72°F), humidity (65%), and a 12-hour light cycle (lights on at 7:00 AM). Monkeys were acclimated to the laboratory personnel and then trained to present their leg for blood collection via saphenous or femoral venipuncture for subsequent assays of plasma steroids. All primate handling procedures were performed in accordance with the NIH guidelines, the Commission on Life Sciences, National Research Council (1996) Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC), and approved by Wake Forest University animal care and use committee. As detailed training procedures were previously published (vide supra), they are not detailed here.
Induction of EtOH Self-Administration
As previously described, a group of 10 monkeys were trained to operate a drinking panel in daily 60-minute sessions and then induced to drink water and later EtOH (4% w/v in water). A separate group of 10 control monkeys were similarly trained, but housed without access to EtOH and did not undergo scheduled induction of any fluids. Monkeys undergoing scheduled induction of EtOH were trained to press the panel for food delivery for their meals, but pellet delivery was contingent upon consumption of a predetermined volume of either water or 4% (w/v) EtOH. Initially, the monkeys were induced to drink water (150 to 227 ml, based on body weight) prior to food delivery for 30 days. Next, induction of EtOH self-administration was initiated with EtOH (4% w/v) as the only fluid available. The monkeys were induced to drink 0.5 g/kg EtOH per day for the first month, 1 g/kg/d for the next month, and finally 1.5 g/kg/d for 30 days.
Chronic EtOH Self-Administration
Following 120 days of scheduled induction, EtOH and water were freely available and food was available in meals during each daily 22-hour session (11:00 AM to 9:00 AM the following day). Details of these procedures were previously published (Vivian et al., 2001 ).
Pharmacological Profiling
A particular advantage of using cohorts studied previously involves the opportunity to examine the relationship between hypothalamic-pituitary-adrenal (HPA) axis function prior to EtOH exposure and subsequent effects of EtOH in various brain regions (Beattie et al., 2017) . Each monkey in this cohort participated in endocrine profiling as previously described . These studies were designed to reflect clinical assessments commonly available in human research protocols. Eight pharmacological challenges were conducted over the course of 4 weeks: naloxone (2 doses), corticotrophin releasing factor, adrenocorticotropic hormone, dexamethasone, EtOH (2 doses, 1 and 1.5 g/kg), and saline. Here, we report data from the saline and EtOH challenges as well as the dexamethasone suppression test in relation to the postmortem 3a,5a-THP levels in the hippocampus.
Tissue Acquisition
As previously described, monkeys underwent a state-of-the-art necropsy protocol (Davenport et al., 2014) within hours of their final access to EtOH in which the brain was removed, cut into 3 blocks, and frozen in isopentane at À35°C. The temporal pole containing the hippocampus was cut from the brain block and shipped by the Monkey Alcohol Tissue Research Resource (http://www.ma trr.com/). The tissue block was subsequently postfixed in 4% paraformaldehyde for 24 hours at 4°C and then stored in 30% sucrose until they were sectioned at 40 lm on a freezing microtome.
Immunohistochemistry
Immunohistochemistry was performed on free-floating sections (6 to 8 sections/animal/brain region) using an affinity-purified 3a,5a-THP sheep antibody as previously described (Beattie et al., 2017) or a commercial MCP-1 antibody. Briefly, sections were rinsed in phosphate buffered saline (PBS), incubated in 1% hydrogen peroxide to block endogenous peroxidase activity, blocked in 10% normal rabbit serum (Vector Laboratories, Burlingame, CA) in PBS to reduce background staining, and then incubated with antibody for 48 hours at 4°C. The 3a,5a-THP antiserum (purchased from Dr. R.H. Purdy) was used at a 1:2,500 dilution, while the MCP-1 antibody (Abcam, Cambridge, MA) was used at 1:200 dilution. The Vectastain Elite ABC kit (Vector Laboratories) was utilized for staining for each antibody, and immunoreactivity was visualized with 3,3'-diaminobenzidine (Sigma-Aldrich, St. Louis, MO) using the manufacturer's recommended protocol.
Immunohistochemistry Analyses
Brain region immunoreactivity was visualized with an Olympus CX41 light microscope (Olympus America, Center Valley, PA), and images were captured with a digital camera (Regita model; QImaging, Burnaby, BC) and analyzed using Bioquant (Nashville, TN) image analysis to obtain linear integrated optical density for immunoreactivity assessment. The microscope, camera, and software were background corrected to eliminate nonspecific labeling and normalized to preset light levels to ensure fidelity of data acquisition. Positive pixel counts of immunoreactivity were quantified from a circumscribed field, delineated as a brain region, divided by the area of the region in square millimeters, and expressed as pixels/ mm 2 . Data from 6 to 8 alternate sequential sections per animal per brain region from a single hemisphere were used to average 1 value per monkey. The experimenter was blind to the condition of each animal when analyses were conducted.
Statistics
Raw pixel densities (pixels/mm 2 ) were analyzed between EtOHna€ ıve controls and EtOH-consuming monkeys using Student's t-test for comparisons in each experiment. Data were further analyzed with alcohol consumption levels as a factor (3: control, heavy, nonheavy) using a 1-way analysis of variance (Statistica; StatSoft Inc., Tulsa, OK). Post hoc analyses were conducted with the NewmanKeuls test. Nonparametric correlations were performed between 3a,5a-THP or MCP-1 raw pixel densities (pixels/mm 2 ) and individual drinking levels (average daily drinking g/kg) for each monkey using Spearman correlations.
RESULTS
Chronic EtOH Consumption Increases 3a,5a-THP in CA1 Hippocampus
3a,5a-THP immunoreactivity was examined in the CA1 hippocampus following 12 months of voluntary EtOH consumption and compared to hippocampal 3a,5a-THP immunoreactivity in control animals that were similarly housed, but without access to EtOH. Overall, EtOH-consuming monkeys showed higher 3a,5a-THP immunoreactivity in CA1 hippocampus compared to control animals (Fig. 1A ). An increase in cellular 3a,5a-THP immunoreactivity (12 AE 2%; t(18) = 3.8, p < 0.05) was observed in the hippocampus CA1 of monkeys that chronically consumed EtOH. The effect of EtOH was largely driven by those animals that drank heavily (≥3 g/kg/d for ≥20% of days), F(2, 17) = 13.3, p < 0.05. Indeed, monkeys classified as heavy drinkers displayed increased (16 AE 2%; p < 0.05) 3a,5a-THP immunoreactivity versus controls (Fig. 1B) , while those classified as nonheavy drinkers (<3 g/kg for ≥20% of days) showed no effect of EtOH consumption. 3a,5a-THP immunoreactivity in the hippocampus of heavy drinkers was also increased (10 AE 2%; p < 0.05) when compared to nonheavy drinkers (Fig. 1B) .
Average Daily Drinking is Correlated with 3a,5a-THP Levels in CA1 Hippocampus
To assess the relationship between EtOH intake and 3a,5a-THP immunoreactivity, we examined Spearman correlation coefficients. 3a,5a-THP immunoreactivity in the hippocampus ( Fig. 2A) was positively correlated (r = 0.76, p < 0.05) with voluntary EtOH consumption (average daily EtOH intake [g/kg]) after 12 months of daily drinking (Fig. 2B) .
These data suggest that 3a,5a-THP immunoreactivity in the CA1 region of the hippocampus is dependent upon EtOH dose.
Chronic EtOH Consumption Reduces MCP-1 Levels in CA1 Hippocampus
Next, we assessed MCP-1 immunoreactivity in the hippocampus of the same monkeys. MCP-1 immunoreactivity was reduced, À23 AE 9%; t(17) = 2.1, p < 0.05, in monkeys that chronically consumed EtOH versus control subjects (Fig. 3A) . The greatest reductions were found in heavy drinkers, F(2, 18) = 5.3, p < 0.05, that displayed significantly reduced (À42 AE 14%; p < 0.05) MCP-1 immunoreactivity (Fig. 3B) compared to controls or nonheavy drinkers (35 AE 10%; p < 0.05; Fig. 3B ). Nonheavy drinkers did not show a significant reduction in MCP-1 immunoreactivity compared to controls.
Average Daily Drinking is Correlated with MCP-1 Levels in Hippocampus
To assess the relationship between EtOH intake and MCP-1 immunoreactivity, we examined Spearman correlation coefficients. MCP-1 immunoreactivity in the hippocampus was inversely correlated (r = À0.78, p < 0.05) with voluntary EtOH consumption [average daily EtOH intake (g/kg)] after 12 months of voluntary drinking (Fig. 4B) . Changes in MCP-1 immunoreactivity in the hippocampus appear to be proportional to the average amount of EtOH consumed. These data suggest that MCP-1 immunoreactivity in the CA1 region of the hippocampus is also dependent upon EtOH dose.
3a,5a-THP Levels are Inversely Correlated with MCP-1 Levels in the CA1 Hippocampus
As EtOH intake appeared to influence both 3a,5a-THP and MCP-1 immunoreactivity in the same animals and these factors have previously been shown to influence EtOH consumption in rodents, we examined the correlation between these factors following 12 months of EtOH self-administration. MCP-1 levels were inversely correlated with 3a,5a-THP levels (r = À0.68, p < 0.05) in the CA1 region of the hippocampus (Fig. 5) . This result indicates a potential relationship between 3a,5a-THP and MCP-1 levels that may influence heavy EtOH consumption.
Neither 3a,5a-THP nor MCP-1 Levels in CA1 Hippocampus are Correlated with Serum Levels of 3a,5a-THP We have previously reported that chronic EtOH consumption reduces circulating 3a,5a-THP levels in these same animals, but that no correlation was found between circulating 3a,5a-THP levels and average daily intake of EtOH (Beattie et al., 2017 ). Here we compared 3a,5a-THP levels in the CA1 hippocampus and serum levels of 3a,5a-THP levels and found no correlation (data not shown). Similarly, we compared hippocampal levels of MCP-1 with circulating 3a,5a-THP and found no correlation (data not shown). Thus, circulating levels of 3a,5a-THP are not indicative of hippocampal levels of 3a,5a-THP or MCP-1 or the average daily EtOH intake of cynomolgus monkeys.
Postmortem 3a,5a-THP and MCP-1 Levels Correlate with HPA Axis Function Prior to EtOH Exposure
A previous study in these same monkeys showed that dexamethasone-induced changes in circulating pregnenolone levels prior to EtOH exposure were correlated with subsequent alcohol intake . We subsequently found that postmortem 3a,5a-THP levels in the lateral amygdala of these monkeys were inversely correlated with dexamethasone-induced changes in circulating pregnenolone measured prior to EtOH exposure (Beattie et al., 2017) . To extend this relationship, we examined postmortem levels of 3a,5a-THP in the hippocampus and found a strong correlation with dexamethasone-induced changes in circulating pregnenolone levels ( Fig. 6A ; r = 0.93, p < 0.05). Dexamethasone-induced changes in plasma pregnenolone levels prior to EtOH exposure were predictive of postmortem 3a,5a-THP levels in the hippocampus. Similarly, MCP-1 levels in CA1 hippocampus were inversely correlated with dexamethasone-induced changes in circulating pregnenolone levels ( Fig. 6B ; r = À0.76, p < 0.05) indicating another factor that was predicted by dexamethasone sensitivity prior to EtOH exposure. As pregnenolone is the precursor of 3a,5a-THP and pregnenolone administration increases 3a,5a-THP levels in rats and humans Porcu et al., 2009 ), we examined whether pregnenolone levels following saline injection or acute EtOH gavage (1.5 g/kg) prior to EtOH exposure were related to postmortem levels of hippocampal 3a,5a-THP following long-term EtOH consumption. No correlation was observed between postmortem 3a,5a-THP and circulating pregnenolone after saline or acute EtOH administration to the EtOH-na€ ıve monkey (data not shown).
DISCUSSION
This study demonstrates increased 3a,5a-THP and decreased MCP-1 immunoreactivity in the CA1 region of the hippocampus following prolonged voluntary EtOH consumption in male cynomolgus monkeys. 3a,5a-THP immunoreactivity is inversely proportional to the average daily intake of EtOH following chronic exposure, while MCP-1 immunoreactivity was directly proportional to average daily drinking. Additionally, 3a,5a-THP and MCP-1 immunoreactivity were inversely correlated in this brain region. The hippocampus is responsible for many aspects of learning and memory and also plays a part in modulating the mesolimbic dopamine system, thought to be important for the development of alcohol use disorders, via projections to other limbic brain regions, including the cortex and amygdala. EtOH is known to affect multiple aspects of hippocampal function including neurotransmission, synaptic plasticity, cell signaling, and adult neurogenesis (Morris et al., 2010) .
The finding that chronic EtOH consumption increases 3a,5a-THP immunoreactivity in monkey hippocampus is consistent with studies in C57BL/6J mice where chronic intermittent EtOH exposure produced increases in CA3 hippocampal 3a,5a-THP immunoreactivity (MaldonadoDevincci et al., 2014) , although findings in Sprague Dawley rats indicate reduced 3a,5a-THP in whole hippocampus following chronic EtOH consumption (Cagetti et al., 2004) . The physiological significance of these changes is unknown, but it has been shown in isolated rat hippocampus that EtOH acutely increases the concentration of 3a,5a-THP as well as the amplitude of GABA A receptor-mediated inhibitory postsynaptic currents recorded from CA1 pyramidal neurons (Sanna et al., 2004) . While neuroactive steroids are generally thought to bind and activate GABA A receptors leading to local inhibition, some neuronal populations within the hippocampus may be acting in an excitatory manner in the presence of 3a,5a-THP. GABA A receptors expressed on presynaptic glutamatergic nerve terminals in rat CA3 hippocampus modulate neurotransmitter release in response to 3a,5a-THP (Iwata et al., 2013) . Thus, an increase in 3a,5a-THP at this site could result in increased excitability. 3a,5a-THP also increases dendritic spine density in cultured hippocampal neurons (Shimizu et al., 2015) . As dendritic spines are the postsynaptic receptive regions enriched in excitatory synapses, certain neuron populations within the hippocampus may act in an excitatory manner following neuroactive steroid interactions. 3a,5a-THP can exert either inhibitory or excitatory effects, depending on the site of action.
The effects of chronic EtOH intake in the CA1 hippocampus are clearly distinct from the decreases in 3a,5a-THP immunoreactivity that was reported in the amygdala of the same monkeys (Beattie et al., 2017) as well as C57BL/6J mice (Maldonado-Devincci et al., 2014) . GABA A receptors in the amygdala of cynomolgus macaques display altered GABA potency following chronic EtOH self-administration as a result of selective reductions in subunit mRNA expression (Floyd et al., 2004) . EtOH-induced changes in receptor function are driven by these alterations in subunit expression and are largely brain region specific. In the putamen of cynomolgus monkeys, prolonged intermittent EtOH consumption decreases GABAergic inhibitory synaptic transmission while increasing glutamatergic excitatory transmission (Cuzon Carlson et al., 2011) . The activity of 3a,5a-THP on GABA A receptor modulation, whether preor postsynaptic, regulates neuronal excitability differently across brain regions. Taken with our previous study, this work reveals differential regulation of 3a,5a-THP levels after long-term, voluntary EtOH consumption between the amygdala and the hippocampus (Beattie et al., 2017) . A similar, differential relationship has been observed in studies conducted in C57BL/6J mice showing reductions in 3a,5a-THP levels in the lateral amygdala after chronic EtOH consumption as well as increases in hippocampus CA3 (MaldonadoDevincci et al., 2014) . In rats, acute EtOH treatment (2 g/kg) leads to reductions in 3a,5a-THP levels the central nucleus of the amygdala, while the CA1 pyramidal cell layer of the hippocampus showed increases in local 3a,5a-THP levels . These observations are consistent with our findings that long-term voluntary EtOH consumption leads to divergent effects in distinct brain regions.
EtOH consumption, withdrawal, and stress are known to activate the innate immune system, resulting in increased neuroimmune signaling molecules. Thus, it was surprising to find a decrease in MCP-1 in monkey CA1 hippocampus in the present study. Previous studies have shown increased MCP-1 in other brain regions in rodent models of EtOH consumption and withdrawal (Knapp et al., 2016) . In orbitofrontal cortex of human postmortem alcoholics, highmobility group box 1, a cytokine-like molecule that activates the innate immune system via the TLR pathways, and TLR2, TLR3, and TLR4 mRNA levels are increased and those levels correlate with lifetime drinking (Crews et al., 2013) . The differential effect on MCP-1 in our study may be due to the precise anatomical localization to CA1 hippocampus, which has not been previously examined or it may relate to the observed increase in 3a,5a-THP immunoreactivity, as there was an inverse correlation between MCP-1 and 3a,5a-THP. Further studies are needed to explore these questions.
The physiological significance of altered MCP-1 in CA hippocampus is unclear. MCP-1 can cause activation and migration of microglia potentially resulting in increased secretions of pro-inflammatory cytokines. It has been shown that MCP-1 knockout mice display reductions in pro- inflammatory cytokine production such as IL-1b and TNF-a (Rankine et al., 2006) . MCP-1 also regulates the release of several neurotransmitters, including glutamate, GABA, and dopamine, and binding to its receptor (CCR2) can lead to cross-desensitization of GABA A receptors (Rostene et al., 2007) . CCR2 activation by MCP-1 results in inhibition of GABA A receptor activity that is likely occurring through a direct receptor-receptor interaction (Gosselin et al., 2005) . Thus, the effects of alcohol-induced changes in MCP-1 could involve such mechanisms. Further studies are required to better understand the differential regulation of MCP-1 across the CNS after chronic alcohol exposure.
The relationship between neuroactive steroid changes and neuroimmune activation following EtOH administration is not yet understood. In this study, an inverse relationship was present between 3a,5a-THP levels and MCP-1 levels in CA1 hippocampus in the cynomolgus monkey following EtOH consumption. Both 3a,5a-THP and cytokines have been implicated in HPA axis dysfunction associated with various disease states, such as depression and drug addiction (Girdler and Klatzkin, 2007; Hueston and Deak, 2014; Kaminski et al., 2005; Morrow et al., 2006) . Following 12 months of EtOH self-administration, cynomolgus monkeys show an inverse correlation between plasma MCP-1 and cortisol as well as changes in other immune-related plasma proteins in relation to HPA axis function (Helms et al., 2012) . In rat hippocampus and frontal cortex, chronic stress-induced glucocorticoids regulate expression of TNF-a, IL-1b, and NFjB (Munhoz et al., 2006) . Known to be present in microglia, MCP-1 has been shown to localize to the cell bodies of some neuron populations. Here we found that MCP-1 exhibited neuronal staining patterns similar to those found with 3a,5a-THP immunostaining, indicating a potential relationship between cytokines and neuroactive steroids following EtOH administration. This relationship, as well as the ability of neuroimmune factors to regulate HPA axis function, could provide an important link between stress response and EtOH consumption.
Earlier studies showed that dexamethasone regulation of circulating pregnenolone in these monkeys was predictive of subsequent EtOH intake . Indeed, the monkeys that exhibited dexamethasone suppression of plasma pregnenolone were classified as nonheavy drinkers in the subsequent 12-month voluntary drinking period. In contrast, the monkeys that exhibited dexamethasone enhancement of plasma pregnenolone were later classified as heavy drinkers. In the current study, we extended this analysis to the postmortem hippocampal 3a,5a-THP levels and found that dexamethasone-induced changes in plasma pregnenolone were directly correlated. We also found an inverse correlation between hippocampus CA1 MCP-1 levels and dexamethasone-induced changes in plasma pregnenolone. It is unclear, however, whether elevated hippocampal 3a, 5a-THP or reduced MCP-1 content preceded or was a consequence of chronic heavy alcohol consumption. What is clear is the presence of a relationship between HPA axis function, neuroimmune regulation, and drinking behavior. Future studies will be required to determine the mechanistic relationships involved in these interactions. From a clinical perspective, these relationships may help identify risk factors or biomarkers for heavy drinking behaviors and allow possible interventions, whether proactive or reactive.
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